stars 1 stars 2 stars 3

DERMOGYN was founded in 2005 thanks to the Pharmaceutical managers and medical specialists protagonists in experimental and clinical research field ,aimed at Drugs and Cosmetics. It was created with the aim of developing parapharmaceutical products, skin cosmetics and medical devices in the Gynecology,Dermatology and Antiaging areas, adjuvants and complementary to traditional therapies to propose Pharmaceutical and Cosmetics industry nationally and internationally. The premise for this decision is a careful analysis of the Pharma markets, which already in the early 2000s denounced a substantial braking concerning innovative proposals, an aspect connected to the growing medical prescription market. here was and still is a great demand of innovative proposals alternatives to the drug.

Dermogyn Questions

The Dermogyn annual revenue was $1 million in 2026.

Dermogyn is based in Milan, Lombardy.

The NAICS codes for Dermogyn are [42, 4242, 42421, 424].

The SIC codes for Dermogyn are [51, 512].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users